Articles in Category: More News

Meet our Founder @ World Orphan Drug Congress in Boston

News from Monday, 08 April 2024.

World Orphan Drug Congress in the USA: 23.04.2024-25.04.2024

Meet one of our GMP QPs @ Analytica in München

News from Monday, 25 March 2024.

Analytica in Germany: 09.04.2024-12.04.2024

Meet our Founder @ 14th PBP World Meeting in Vienna

News from Wednesday, 14 February 2024.

World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology in Austria: 18.03.-21.03.2024

Meet our Founder @ 16th EBF Open Symposium in Barcelona

News from Wednesday, 08 November 2023.

EBF OS in Spain: 15.11.-17.11.2023

CAD Feasibility

News from Wednesday, 25 October 2023.

Complementing the ELSD with a charged aerosol detector and finding out potentials for esp. Tween, PEG and Protein Quantitation

First «1 2 345 6 7 8 »Last

Did you know:

We are

giving away

a lot of our know-how in Hermann’s book “HPLC Methods for Clinical Pharmaceutical Analysis”.

(See R&D)
We are

always eager
for difficult analytical challenges.
They say

it’s not feasible?

Give us a try.
Every day

we are learning something
about bioanalysis.
A quote from one of our collaborators concerning PEG tissue analysis: I am totally blown away by the fact that not only do you have measurable levels of PEG

but they are also dose-dependent!!

Amazing stuff!!
pharm-analyt has been
GLP certified for over

30 years.
Our first look might be

invaluable

and it’s for free!
"Never give in,
never, never
never, never, in nothing great or small."
(Sir Winston Churchill)
Why our founder’s

hairstyle

sometimes reminds of a well known nuclear physicist? Tell us if you know!
A part of our historical
premises used to be a

bakery

before we moved in.
pharm-analyt has developed bioanalytical assays for more than

400 compounds.
Inpassible…? Imposibol…? Unpossibal…?

Sorry, we’re just not
familiar with this word.
pharm-analyt is

fully family-owned.
pharm-analyt was founded

long before

mass spec was widespread.
Rumors say:

…Of all of our equipment, the
highest throughput is with our

espresso machine?!
pharm-analyt has developed
multiple ways of

stabilizing peptides

in plasma.
pharm-analyt has sold

4 European patents

on biomarkers.
pharm-analyt requires as little as

50 µL

sample volume for clinical studies,
if necessary.
pharm-analyt has been
GMP certified for over

20 years.
We work, where the

Austrian Emperors

went on vacation.

(Historical town of Baden)
We are

locals

in the area of trace analysis.
pharm-analyt has over

100 publications

in peer reviewed journals.
Our most sensitive method has an LLOQ of

0.00000000000005

g/mL plasma.

= 50 femtogram/mL
or 50 x 10^-15 g/mL
or 200 g sugar in lake Chiemsee!
In a number of cases chemical

derivatization

might be the key to
success in bioanalysis.
Throughout the

40 years

of pharm-analyt’s existence it
was always equipped with
state-of-the-art instrumentation.
“Edelweiss”

is not the Austrian anthem.
It is our national flower.
50 %

of the analytical know-how lies
in sample preparation.
Rumors say:

…For a remarkable bottle of

Chardonnay,

our founder Hermann Mascher would conduct the analysis of a large clinical study for free. :-)
pharm-analyt has won

several awards

for innovation.
pharm-analyt has discovered biomarkers that will save

the lives of thousands of children

suffering from various rare diseases.
pharm-analyt was

one of the first

CROs to switch to electronic archiving.
You will get the clinical PK profile of

250

common drugs from us for free.

Contact us.

›

‹

Articles in Category: More News

giving away

always eager

it’s not feasible?

Every day

but they are also dose-dependent!!

30 years.

invaluable

never, never

hairstyle

bakery

400 compounds.

Inpassible…? Imposibol…? Unpossibal…?

fully family-owned.

long before

espresso machine?!

stabilizing peptides

4 European patents

50 µL

20 years.

Austrian Emperors

locals

100 publications

0.00000000000005

derivatization

40 years

“Edelweiss”

50 %

Chardonnay,

several awards

the lives of thousands of children

one of the first

250